Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- eCTD Progresses to Step 4 at ICH in Brussels
July 18, 2013
- 2nd Committee on Drugs to Discuss Approval for Asthma Treatment Flutiform on July 26
July 17, 2013
- MHLW, US FDA to Exchange Information with a View to Standardizing Review Guidelines for Regenerative Medicines
July 17, 2013
- Health Ministry to Set Up Committee on Diovan Studies, Compile Preventive Measures for Clinical Data Manipulation
July 16, 2013
- MHLW Presses Kyoto Prefectural University of Medicine to Carry on Diovan Probe
July 16, 2013
- Health Ministry Requests Revisions of Precautions for Invega Tablets, Other Drugs
July 12, 2013
- Generic Substitution Reduced Drug Expenditure by 16.3 Billion Yen Over Last 4 Years: Kyokai Kenpo
July 11, 2013
- TPP Member States to Brief Japan on Drug Pricing, Intellectual Property on July 25
July 9, 2013
- Dr Nakashima of PMDA Proposes Freeze on NHI Prices of Generics for Which Companies Take Steps to Ensure Stable Supplies
July 9, 2013
- Campaign Starts for Upper House Race, Organized Votes Eyed
July 8, 2013
- Notification Calls for Cooperation to Prevent Local Shortages of Rubella Vaccine
July 5, 2013
- Health Ministry to Give Guidance to Parties Suspected of Data Manipulation in Anti-Obesity Drug Clinical Study
July 4, 2013
- Expiration Date for Tamiflu Capsules Extended from 7 to 10 Years
July 3, 2013
- Notification Calls for Simultaneous Filing of Applications for Companion Diagnostics and Drugs
July 3, 2013
- Deputy Mayor of Ikoma Proposes Reduction of Dispensing Fees for Pharmacies With Low Generic Dispensing Rates
July 2, 2013
- MHLW Project Stops Short of Setting Generic Evaluation Criteria
July 1, 2013
- Price Settlement Rate for Chain Pharmacies Fell Below 50% in FY2012: Survey
July 1, 2013
- MHLW Aims for Passage of Bill to Amend PAL during Extraordinary Diet Session This Autumn
July 1, 2013
- Study Group Approves Guidelines for Use of Medical Information Database During Trial Period
June 28, 2013
- Cost-Effective Assessment for Medical Devices Presented at CSIMC Subcommittee; Reps Say They Want Examples for Pharmaceuticals Too
June 27, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…